Skip to main content
. 1998 May;5(3):348–354. doi: 10.1128/cdli.5.3.348-354.1998

TABLE 1.

Serotype, serosubtype, and PorB VR type characteristics of N. meningitidis strains analyzed

Strain Sourceh Serogroup Serotype
Serosubtypef Accession no.c PorB protein classd PorB VR typee
Originala Proposedb 1 2 3 4
Prototype strains
 M1080 FDA B 1 19,7,1 P1.7,1 X65530 3 19 Ac 7a 1
 B16B6 FDA B 2a 2a P1.5,2 X67937 2 C Eb 2a C
 2996 FDA B 2b 2b P1.5,2 X67939 2 C Ea 2b C
 2396 SIF B 2c 2c P1.5,2 U92911 2 C 2c 2bb Db
 126E SIF C 3 19,10 P1.5,2 U07191 3 19 Ac 10 14a
 Z-4008j MPIG B 4 4,7 P1.4 U59868 3 4 D 7 14a
 H-276k MPIG B 4 4,7 P1.10 U59870 3 4 D 7 14a
 M981 FDA B 4 4,7 P1− X65531 3 4 B 7 14a
 M992 FDA B 5 5 P1.7,1 U92909 2 Ca Ec 5 Ca
 M990 FDA B 6 16,6 P1.6 X67936 2 D 16 6 D
 M978 FDA B 8 19,10 P1.7,1 U07189 3 19 Aa 10 14a
 M982 FDA B 9 NT P1.9 X67938 2 C E B Da
 N.34/94 IAL B NTi 19,10 P1.4 U34194 3 19 Db 10 Aa
 M136 SIF B 11 16,11 P1− U95366 2 D 16 11 D
 S3032 SIF B 12 19,7 P1.12,16 X65534 3 19 Ab 7a A
 S3446 SIF B 14 19,14 P1.23,14 U07188 3 19 Db 7c 14
 H.44/76 SIF B 15 15 P1.7,16 X83428 3 A A A Ba
 BB393 FDA B 15 15 P1.3 U62905 3 A A A Ba
 H355 FDA B 15 15 P1.15 M68962 3 A A A B
 60E FDA C 16 16,2bg P1.7,1 U92908 2 C 16 2ba Db
 6557 FDA B 17 17,7 P1.23,14 U07190 3 B C 7 14b
 190I FDA B 18 19,10 P1.6 U07192 3 19 Aa 10 14a
 6940 FDA B 19 19,10 P1.6 U11030 3 19 Ac 10 14a
 35E SIF C 20 2c P1.1 X67940 2 C 2c 2bb Db
 M1027 FDA A 21 4,21 P1− U59869 3 (4) D 7b (21)
 503/93 NIPH B 22 NT nt U92906 2 C Ed 5a Db
Additional strains
 94010 LCDCTP C 2a 2a P1.5,2 U92907 2 C Eb 2a C
 M986 FDA B 2a 2a P1.5,2 U92912 2 C Eb 2a C
 N.446/95 IAL C 2b 2b P1.10 U92910 2 C Ea 2b C
 N.781/95 IAL C 2b 2b P1.10 U92913 2 C Ea 2b C
 N.862/95 IAL C 2b 2b nt U94962 2 C Ea 2b C
 N.1302/95 IAL B 2b 2b P1.5 U92905 2 C Ea 2b C
 N.459/93 IAL B 4 4,7 P1.7,1 U92903 3 4 Da 7 14a
 N.585/94 IAL B 4 4,7 P1.13 U92899 3 4 B 7 14a
 N.300/94 IAL B 4 4,7 P1.9 U59866 3 4 B 7 14a
 CU385 FDA B 4 4,7 P1.15 L03786 3 4 B 7 14a
 N.1281/95 IAL B 4 4,7 nt AF012017 3 4 B 7 14a
 N.150/88 IAL B 4 4,7 P1.15 U59872 3 4 D 7 14a
 N.44/89 IAL B 4 4,7 P1.15 U59871 3 4 D 7 14a
 N.155/94 IAL B 4 4,7 P1.15 U94960 3 4 D 7 14a
 N.610/93 IAL B 4 4,7 P1.15 U59867 3 4 D 7 14a
 N.314/95 IAL B 4 4,7 P1.15 AF012015 3 4 D 7 14a
 N.454/95 IAL B 4 4,7 P1.15 AF012013 3 4 D 7 14a
 N.45/95 IAL B 4 4,7 P1.15 AF012014 3 4 D 7 14a
 501 CDC B 4,15 4,15 nt AF002250 3 4 A A Ba
 N.294/97 IAL B 15 15 P1.16 AF012018 3 A A A Ba
 N.109/93 IAL B 4 4,10 P1.9 U92904 3 4b D 10 14a
 N.23/97 IAL B 4 4,10 P1.15 AF001321 3 4 D 10 14a
 N.520/95 IAL B 4 4,10 P1.15 AF012016 3 4 B 10 14c
 N.163/94 IAL B 8 19,10 P1.6 U92902 3 19 Aa 10 14a
 N.19/93 IAL B 7 7 nt U92901 3 A D 7d 14a
 N.105/93 IAL B 17 17,7 nt U92900 3 B C 7 14b
 N.1342/96 IAL B 17 17,7 P1.7,16 AF001322 3 B C 7 14b
 N.1329/96 IAL B 17 17,7 P1.7,16 AF001319 3 B C 7 14b
 N.405/94 IAL B 19 19,7,1 nt U94961 3 19 Ac 7a 1
 N.1434/96 IAL B 19 19,14 P1.23,3 AF001323 3 19 Db 7c 14
 N.1450/96 IAL B 19 19,14 P1.23,3 AF001320 3 19 Db 7c 14
 N.1454/96 IAL B 19 19,14 P1.23,3 AF001318 3 19 Db 7c 14
 N.257/93 IAL B NT NT nt U92914 2 Cb Ed C Ca
 J129 GB B 4 (4),(7)h P1.15 X67933 3 4a D 7 14a
 BB1350 GB B 4 (4),(7) UK U07193 3 4 D 7 14a
 PM36 GB B 4 (4),(7) P1.15 X79464 3 4 B 7 Bb
 PM40 GB B 4 (4),(7) P1.2 X78579 3 4 B 7 14a
 B54 GB A 4,21 (4),(21) P1.X,9 X67934 3 4 D 7b 21
 B227 GB A 4,21 (4),(21) P1.5,9 X67935 3 4 D 7b 21
 G1960 GB B 15 (15) P1.7,16 X67932 3 Aa A A Ba
 MC58 GB B 15 (15) UK X65532 3 A A A Ba
a

Original serotypes were defined by Frasch et al. (9) by using rabbit immunosera and MAbs. 

b

Proposed serotypes were characterized by dot blotting reactions using serotype-defining MAbs, including the new MAbs 7, 10, and 19 as described in the text. Because we did not have access to eight meningococcal strains from sequences obtained from the GenBank, the serotyping of those strains was not repeated in our laboratory; the serotypes based on predicted reactions with the serotype-defining MAbs are presented in parentheses. 

c

Boldface GenBank accession numbers are those for which the nucleotide sequences were determined in this work. 

d

PorB protein classes were defined by SDS-PAGE (24). 

e

PorB VR types were defined by a comparison of MAb reactivities and amino acid sequence homology as described in the text. 

f

P1−, no expression of PorA class 1 protein by SDS-PAGE; nt, nonserosubtypeable; UK, unknown serosubtype. 

g

VR3-2ba can only be detected by dot blotting using serotype-defining MAb 2b (F1-9H10/1B3) or 1082E7. 

h

MPIG, Max-Planck-Institut Fur Molekulare Genetic; LCDCTP, Laboratory Center for Disease Control, Tunney’s Pasture. GB, GenBank. 

i

NT, nonserotypeable. 

j

882066. 

k

870227.